GB1492973A - Process for preparing injectable compositions - Google Patents

Process for preparing injectable compositions

Info

Publication number
GB1492973A
GB1492973A GB7156/74A GB715674A GB1492973A GB 1492973 A GB1492973 A GB 1492973A GB 7156/74 A GB7156/74 A GB 7156/74A GB 715674 A GB715674 A GB 715674A GB 1492973 A GB1492973 A GB 1492973A
Authority
GB
United Kingdom
Prior art keywords
allergen
dialdehyde
extract
tyrosine
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7156/74A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB7156/74A priority Critical patent/GB1492973A/en
Priority to IE158/75A priority patent/IE40370B1/xx
Priority to ZA00750634A priority patent/ZA75634B/xx
Priority to AU77943/75A priority patent/AU489860B2/en
Priority to FR7503870A priority patent/FR2261013B2/fr
Priority to NLAANVRAGE7501582,A priority patent/NL186295C/xx
Priority to DE2505814A priority patent/DE2505814C2/de
Priority to JP50018110A priority patent/JPS5822444B2/ja
Priority to BE153404A priority patent/BE825579R/xx
Priority to US05/729,489 priority patent/US4070455A/en
Publication of GB1492973A publication Critical patent/GB1492973A/en
Priority to KE3113A priority patent/KE3113A/xx
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
GB7156/74A 1974-02-16 1974-02-16 Process for preparing injectable compositions Expired GB1492973A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB7156/74A GB1492973A (en) 1974-02-16 1974-02-16 Process for preparing injectable compositions
IE158/75A IE40370B1 (en) 1974-02-16 1975-01-27 Process for preparing injectable compositions
ZA00750634A ZA75634B (en) 1974-02-16 1975-01-30 Process for preparing injectionable compositions
AU77943/75A AU489860B2 (en) 1974-02-16 1975-02-05 Process for preparing injectionable compositions
FR7503870A FR2261013B2 (US20100154141A1-20100624-C00001.png) 1974-02-16 1975-02-07
NLAANVRAGE7501582,A NL186295C (nl) 1974-02-16 1975-02-11 Werkwijze voor het bereiden van fijnverdeelde microdeeltjes van tyrosine, waarin een allergeen is gedispergeerd.
DE2505814A DE2505814C2 (de) 1974-02-16 1975-02-12 Verfahren zur Herstellung feinverteilter Mikropartikel von Tyrosin mit einem Gehalt eines darin dispergierten, mit Glutaraldehyd modifizierten Allergens und diese Mikropartikel als Wirkstoff enthaltende injizierbare Lösung
JP50018110A JPS5822444B2 (ja) 1974-02-16 1975-02-14 ヘンセイアレルゲンオユウスルチロシンノ セイゾウホウ
BE153404A BE825579R (fr) 1974-02-16 1975-02-14 Procede pour la preparation de compositions injectables
US05/729,489 US4070455A (en) 1974-02-16 1976-10-04 Process for preparing injectable desensitizing compositions and products thereof in microparticle form
KE3113A KE3113A (en) 1974-02-16 1981-01-21 Process for preparing injectable compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7156/74A GB1492973A (en) 1974-02-16 1974-02-16 Process for preparing injectable compositions

Publications (1)

Publication Number Publication Date
GB1492973A true GB1492973A (en) 1977-11-23

Family

ID=9827690

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7156/74A Expired GB1492973A (en) 1974-02-16 1974-02-16 Process for preparing injectable compositions

Country Status (9)

Country Link
JP (1) JPS5822444B2 (US20100154141A1-20100624-C00001.png)
BE (1) BE825579R (US20100154141A1-20100624-C00001.png)
DE (1) DE2505814C2 (US20100154141A1-20100624-C00001.png)
FR (1) FR2261013B2 (US20100154141A1-20100624-C00001.png)
GB (1) GB1492973A (US20100154141A1-20100624-C00001.png)
IE (1) IE40370B1 (US20100154141A1-20100624-C00001.png)
KE (1) KE3113A (US20100154141A1-20100624-C00001.png)
NL (1) NL186295C (US20100154141A1-20100624-C00001.png)
ZA (1) ZA75634B (US20100154141A1-20100624-C00001.png)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044947A1 (en) * 1997-04-05 1998-10-15 Allergy Therapeutics Limited Allergen formulation
EP0988862A2 (en) * 1998-09-21 2000-03-29 Allergy Therapeutics Limited Formulation for use in immunisation
EP2042192A2 (en) 1997-10-30 2009-04-01 Laboratorios LETI, S.L. Tolerogenic fragments of natural allergens
US8470331B2 (en) 2000-01-14 2013-06-25 Allergy Therapeutics (Uk) Limited Composition of antigen and glycolipid adjuvant for sublingual administration

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541201A (en) * 1968-12-18 1970-11-17 Ethan Alan Brown Novel sodium chloride encapsulated injectionable substances
BE754523A (fr) * 1969-08-06 1971-02-08 Beecham Group Ltd Vaccins
GB1377074A (en) * 1971-07-13 1974-12-11 Beecham Group Ltd Process for preparing injectable compositions

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044947A1 (en) * 1997-04-05 1998-10-15 Allergy Therapeutics Limited Allergen formulation
AU729631B2 (en) * 1997-04-05 2001-02-08 Allergy Therapeutics Limited Allergen formulation
US7718178B2 (en) 1997-04-05 2010-05-18 Allergy Therapeutics Limited Allergen formulation
US8105605B2 (en) 1997-04-05 2012-01-31 Allergy Therapeutics (Uk) Ltd. Allergen formulation
EP2042192A2 (en) 1997-10-30 2009-04-01 Laboratorios LETI, S.L. Tolerogenic fragments of natural allergens
EP0988862A2 (en) * 1998-09-21 2000-03-29 Allergy Therapeutics Limited Formulation for use in immunisation
EP0988862A3 (en) * 1998-09-21 2001-06-20 Allergy Therapeutics Limited Formulation for use in immunisation
US6440426B1 (en) 1998-09-21 2002-08-27 Allergy Therapeutics Limited Antigen-containing formulation and methods of use thereof
US7815920B2 (en) 1998-09-21 2010-10-19 Allergy Therapeutics (UK) Ltd Method of preparing an antigen-containing formulation
US8470331B2 (en) 2000-01-14 2013-06-25 Allergy Therapeutics (Uk) Limited Composition of antigen and glycolipid adjuvant for sublingual administration

Also Published As

Publication number Publication date
FR2261013A2 (US20100154141A1-20100624-C00001.png) 1975-09-12
AU7794375A (en) 1976-08-05
NL7501582A (nl) 1975-08-19
ZA75634B (en) 1976-01-28
FR2261013B2 (US20100154141A1-20100624-C00001.png) 1978-07-21
IE40370L (en) 1975-08-16
JPS5822444B2 (ja) 1983-05-09
DE2505814C2 (de) 1984-11-15
KE3113A (en) 1981-02-20
NL186295C (nl) 1990-11-01
BE825579R (fr) 1975-08-14
DE2505814A1 (de) 1975-09-18
IE40370B1 (en) 1979-05-09
NL186295B (nl) 1990-06-01
JPS50116626A (US20100154141A1-20100624-C00001.png) 1975-09-12

Similar Documents

Publication Publication Date Title
US4070455A (en) Process for preparing injectable desensitizing compositions and products thereof in microparticle form
IE36426B1 (en) Process for preparing injectable compositions
GB1492973A (en) Process for preparing injectable compositions
EP0363835B1 (de) Verwendung von Zink- oder Eisenhydroxid zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
CH628246A5 (de) Verfahren zur herstellung eines schuetzenden pertussis-antigens.
CH526590A (de) Verfahren zur Herstellung von Amiden und deren Salzen aus einem sauren Polysaccharid und komplexen, Aminogruppen enthaltenden organischen Verbindungen
US3201382A (en) Process for preparing a biochemically active polypeptide from sheep pituitary growthhormone
EP0027664A1 (de) Verwendung des Proteins PP5, seiner Derivate oder der gegen dieses Protein gerichteten Antikörper zur Konzeptionsverhütung oder Schwangerschaftsunterbrechung
US1914824A (en) Process for the preparation of humous colloids
Kay The reversibility of the action of urease of soy bean
US2555276A (en) Production of amino acids from protein
DE719026C (de) Verfahren zur Herstellung von Praeparaten, die das Kreislaufhormon Kallikrein enthalten
US2193523A (en) Vitamin preparation
SU674990A1 (ru) Способ получени двуокиси титана
GB1240130A (en) Slow-release adsorbed allergens
US2166133A (en) Therapeutically valuable gold compounds and a method for producing the same
DE3727987A1 (de) Pharmazeutische struktur
US1608288A (en) Process of manufacture of calcium arsenate
DE1221643C2 (de) Verfahren zur herstellung von humanhistaminazoalbuminen
DE836802C (de) Verfahren zur Herstellung neuer Triazolopyrimidinderivate
DE2540523A1 (de) Derivate von amoxycillin, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE922350C (de) Verfahren zur Herstellung von Mitteln zur Foerderung des Pflanzenwachstums aus Xerogelen
AT249376B (de) Verfahren zum Herstellen eines feinverteilten, linearen, synthetischen Polyamides
SU674863A1 (ru) Привод станка
DE1144730B (de) Verfahren zur Herstellung eines Sulfonamidderivates

Legal Events

Date Code Title Description
PS Patent sealed